Document is current
Any future updates will be listed below
-
Authors
Maillart, Elisabeth https://orcid.org/0000-0001-7699-0328
Todesco, Eve
Assoumou, Lambert
Beigneux, Ysoline
Lubetzki, Catherine
Papeix, Caroline
De Paz, Raphael
Dubessy, Anne-Laure
Djebara, Siham
Louapre, Céline
Pourcher, Valérie
- License Information
-
More Information
Article History
Received: 1 November 2023
Revised: 22 December 2023
Accepted: 26 December 2023
First Online: 11 January 2024
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest in this manuscript. EM reports research support from Biogen and personal fees for lectures and advisory boards from Alexion, Biogen, Horizon, Janssen, Merck, Novartis, Roche, Sanofi, Teva. CLo has received consulting, speaker or travel fees from Merck, Roche, Biogen, Novartis, Teva and Sanofi, and a research support from Biogen. ET, LA, RD, SD, YB, ALD report no disclosure. CLu reports research support from Merck and participates in advisory boards for Biogen, Merck, Rewind and Roche. CP reports research personal fees for lectures and advisory boards from Alexion, Biogen, Horizon, Merck, Novartis, Roche and Sanofi. VP reports research personal fees for lectures and advisory boards from Roche, Alexion, Merck.
